Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 252 | 218 | 227 | 222 | 148 |
| Cost of Goods | 120 | 111 | 90 | 75 | 73 |
| Gross Profit | 132 | 107 | 136 | 147 | 75 |
| Operating Expenses | 220 | 199 | 224 | 454 | 623 |
| Operating Income | -88 | -92 | -88 | -307 | -548 |
| Interest Expense | 59 | 70 | 70 | 72 | 68 |
| Other Income | 517 | -2 | -488 | 161 | 1 |
| Pre-tax Income | 370 | -164 | -645 | -218 | -615 |
| Net Income Continuous | 370 | -164 | -645 | -218 | -615 |
| Net Income | $370 | $-164 | $-645 | $-218 | $-615 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $429 | $-94 | $-542 | $-113 | $-514 |